Portfolio Update

RNS Number : 3037Z

Intl. Biotechnology Trust PLC

18 September 2009

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC    

Portfolio update as at 31 August 2009                    

Total Net Assets	£97.9m
NAV per share	151.0p
Share Price	120.8p
Total value of unquoted investments	£19.1m
Total number of portfolio companies	60
Cash	4%
Cash committed and reserved to unquoted investments	12%
Portfolio companies with < 1 year of cash	23%

Top Ten Holdings

Company Name	% NAV	Market Value
Micromet	9.33	9,131,109
Celgene	5.66	5,536,081
Amgen	5.46	5,347,211
Gilead Sciences	4.36	4,270,181
HSBC Sterling Liquid Fund B shares	3.58	3,500,264
Alexion Pharmaceuticals	3.34	3,273,403
Genzyme	3.20	3,131,487
Affymax	2.98	2,913,884
Wright Medical	2.94	2,882,595
EV3	2.83	2,770,250
	-----------	--------------
Total	43.68	42,756,465

Geographical Allocation	%
United States	79
Europe	16
Cash	4
Australia	1
	-----------
Total	100

Quoted/Unquoted allocation	%
Quoted	76
Unquoted	20
Cash	4
	-----------
	100

BNP Paribas Secretarial Services Limited

Company Secretary

18 SEPTEMBER 2009

 

END

 

 

PFUBGGDCDDBGGCI